MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem Highlights MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE MMA.INC to participate directly in revenue generated across its global customer base Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term New York, NY, May 12, 2026 (GLOBE NEWSWIRE) -- Mixed Martial Arts Group Limited (NYSE American: MMA) (“MMA” or the “Company” and doing business as MMA.INC), today announced an exclusive strategic marketing partnership with The Precision Peptide Company Inc. (CSE: BPC; OTCQB: PNGAF), a U.S. manufactured and third party tested peptide company focused on peptide recovery and wellness products. Under the agreement, MMA.INC will market Precision's products across its global combat sports ecosystem and will receive 50% of net revenue derived from MMA-Sourced Sales during the first twelve months of the partnership, followed by an ongoing 25% share of net revenue from MMA-Sourced Sales for the remainder of the Term.